Insider Transactions Reported by 3 Insiders of Addex Therapeutics Ltd.

Symbol
ADXN on Nasdaq
Location
Geneva, Switzerland

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Addex Therapeutics Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Isaac Manke Director 18 Mar 2026
Jason Raleigh Nunn Director 18 Mar 2026
Timothy Mark Dyer Chief Executive Officer, Director, 10%+ Owner 18 Mar 2026

Recent Insider Transactions by Companies or Individuals for Addex Therapeutics Ltd.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Timothy Mark Dyer ADXN Common stock 0 16,848,979 18 Mar 2026 Direct
Jason Raleigh Nunn ADXN Common Stock 0 219,561 18 Mar 2026 Direct
Isaac Manke ADXN Common Stock 0 219,561 18 Mar 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.